Differences

This shows you the differences between two versions of the page.

--- pharmaceutical_companies:bristol-myers_squibb [2022/01/17 12:18]
liam
+++ pharmaceutical_companies:bristol-myers_squibb [2025/01/10 00:49] (current)
liam
@@ Line 3: / Line 3: @@
 {{ :pharmaceutical_companies:bms_logo_tm.png?200|}}
-Bristol-Myers Squibb holds the exclusive license to develop, manufacture and commercialize the monoclonal antibody treatment owned by [[:Rockefeller University]].
+Bristol-Myers Squibb holds the exclusive license to develop, manufacture and commercialize the monoclonal antibody treatment owned by [[:Rockefeller University]].((Bristol-Myers Squibb. (2021, September 7). //COVID-19 Updates.// Retrieved December 6, 2021, from
+https://www.bms.com/about-us/responsibility/coronavirus-updates.html))
-The company is also part of the [[:COVID-19 Therapeutics Accelerator]] funded by the [[:Bill & Melinda Gates Foundation]], [[:Wellcome Trust]], and [[:Mastercard]] to “accelerate treatments, [[:vaccines]], and diagnostics”.
+The company is also part of the [[:COVID-19 Therapeutics Accelerator]] funded by the [[:Bill & Melinda Gates Foundation]], [[:Wellcome Trust]], and [[:Mastercard]] to “accelerate treatments, [[:vaccines]], and diagnostics”.((//Our Research Efforts.// (2021, September 7). Bristol-Myers Squibb. https://archive.ph/WjOyF))
+===== External links =====
+  * [[https://www.whiteroseintelligence.com/bristol-myers-squibb/|White Rose Wiki]]